{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Ffd27abc7-d3ad-4824-a2f0-64be7c1f9c29","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes \u2014 Part 3 of a 3-Part Series\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/fd27abc7-d3ad-4824-a2f0-64be7c1f9c29\"></iframe>","title":"Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes \u2014 Part 3 of a 3-Part Series","description":"Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png"}